TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
155,112
|
147,644
|
166,042 |
Financial expenses |
586
|
301
|
345 |
Earnings before taxes |
6,253
|
2,991
|
11,131 |
Total assets |
49,581
|
48,213
|
40,286 |
Current assets |
39,211
|
36,040
|
32,728 |
Current liabilities |
10,767
|
11,784
|
14,331 |
Equity capital |
28,122
|
24,860
|
21,861 |
- share capital |
987
|
1,057
|
1,025 |
Employees (average) |
41
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.7%
|
51.6%
|
54.3% |
Turnover per employee |
3,601
|
4,370 | |
Profit as a percentage of turnover |
4.0%
|
2.0%
|
6.7% |
Return on assets (ROA) |
13.8%
|
6.8%
|
28.5% |
Current ratio |
364.2%
|
305.8%
|
228.4% |
Return on equity (ROE) |
22.2%
|
12.0%
|
50.9% |
Change turnover |
17,250
|
-23,543
|
9,509 |
Change turnover % |
13%
|
-14%
|
6% |
Chg. No. of employees | 3 | ||
Chg. No. of employees % | 8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.